Check Your Eligibility

Answer a few questions to see if you may qualify for this trial.

Step 1 of 8

Do you have uveal (eye) or cutaneous (skin) melanoma with molecular residual disease (MRD) that has been confirmed twice in blood tests during screening?

This trial is specifically for patients with early-stage melanoma detected only through blood tests (MRD), not visible tumors. The cancer must be confirmed twice to ensure accuracy.

Show original medical criteria

Uveal or cutaneous melanoma with MRD detected in molecular screening, and repeat confirmation of MRD in the sample taken as part of screening for the main study

This is informational only — not medical advice. Always discuss eligibility with your oncologist.